Evaluating the Efficacy and Safety of Co-administrated Rosuvastatin/Ezetimibe and Telmisartan

NCT03872232 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

180

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypercholesterolemia
Hypertension

Interventions

DRUG: Ezetimibe/Rosuvastatin
DRUG: Telmisartan

Sponsor

Addpharma Inc.